Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;60(3):390-404.
doi: 10.1007/s12031-016-0825-5. Epub 2016 Sep 22.

Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets

Affiliations
Review

Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets

Alexandra Grubman et al. J Mol Neurosci. 2016 Nov.

Abstract

Given the importance of microglia to inflammatory, phagocytic and synaptic modulatory processes, their function is vital in physiological and pathological brain. The impairment of microglia in Alzheimer's disease has been demonstrated on genetic, epigenetic, transcriptional and functional levels using unbiased systems level approaches. Recent studies have highlighted the immense phenotypic diversity of microglia, including the ability to adopt distinct and dynamic phenotypes in ageing and disease. We review the origins and functions of healthy microglia and the established and emerging models and techniques available for their study. Furthermore, we highlight recent advances on the role, heterogeneity and dysfunction of microglia in Alzheimer's disease and discuss the potential for therapeutic interventions targeting microglia. Microglia-selective molecular fingerprints will guide detailed functional analysis of microglial subsets and may aid in the development of therapies specifically targeting microglia.

Keywords: Alzheimer’s disease; Diversity; Heterogeneity; Microglia; Stem cell models; Therapeutic.

PubMed Disclaimer

References

    1. Nat Genet. 2011 May;43(5):436-41 - PubMed
    1. Lancet Neurol. 2015 Apr;14(4):388-405 - PubMed
    1. Ann Neurol. 1991 Oct;30(4):572-80 - PubMed
    1. Neurotherapeutics. 2007 Oct;4(4):571-9 - PubMed
    1. Nat Rev Drug Discov. 2010 Dec;9(12):971-88 - PubMed

LinkOut - more resources